Resources

The Prospective Country Evaluation (PCE) is an independent evaluation of the Global Fund commissioned by the Global Fund’s Technical Evaluation Reference Group (TERG). The PCE evaluates how Global Fund policies and processes play out in country in real time and aims to provide high quality, actionable and timely information to national program implementers and Global Fund policymakers. The PCE is implemented by the Infectious Diseases Research Collaboration (IDRC) in collaboration with IHME and PATH.This report describes key findings from early implementation of the newly approved grants from January–November of 2018.

The first human milk bank in Kenya was recently inaugurated at Pumwani Maternity Hospital in Nairobi, opening a new frontier in the country’s efforts to save newborn babies and safeguard their future health. This brief looks at this new development to provide information for other counties and healthcare providers elsewhere, who may be interested in setting up similar facilities in their settings.

This fact sheet describes PATH’s work in maternal immunization—an approach of vaccinating during pregnancy to protect a mother and/or her infant. It covers work across vaccine projects targeting respiratory syncytial virus, Group B Streptococcus, influenza, and pertussis—infections that disproportionately threaten mothers and/or newborns.

These short training videos are intended for self-injection clients and health workers learning to administer the contraceptive subcutaneous DMPA (DMPA-SC or Sayana® Press). DMPA-SC's user-friendly design means that any trained person can administer it, including community health workers, pharmacists, and women themselves.The two videos are available in English, French, Portuguese, and Spanish on the DMPA-SC Resource Library. If you are interested in customizing these videos for your family planning program, we can share the voiceover scripts and video files. For more information, please email FPoptions@path.org.

This brief, developed by the Advancing Maternal Immunization (AMI) collaboration, describes the activities required in the near- and mid-to long-term to generate key evidence and achieve the necessary conditions for advancing respiratory syncytial virus (RSV) maternal immunization in low- and middle-income countries. It is a companion to AMI's Advancing RSV Maternal Immunization: A Gap Analysis Report, which describes the evidence, information, and policy needs of global and country decision-makers, public health program planners, and implementers who might be involved in decision-making and introducing maternal RSV vaccines.AMI is a collaboration of cross-sectoral experts convened by PATH and WHO with the purpose of advancing RSV maternal immunization.Related links:A Roadmap for Advancing RSV Maternal ImmunizationAdvancing Maternal ImmunizationAdvancing RSV Maternal Immunization: A gap analysis brief